Guyana vs Nepal: Cause of death, by non-communicable diseases, ages 15-59, female
Guyana
53.6%
in 2021
Nepal
53.3%
in 2021
Guyana rank
119th
Nepal rank
121st
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Guyana
- Nepal
How they compare
Guyana currently reports 53.6% against 53.3% in Nepal, a difference of 0.3%.
Across all 6 years both countries report, Guyana has been ahead every year.
Guyana ranks 119th and Nepal ranks 121st of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.6% | 41.3% | 22.3% | Guyana |
| 2010s | 66.4% | 53.2% | 13.2% | Guyana |
| 2020s | 59.6% | 55.1% | 4.5% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Guyana or Nepal?
- Guyana, at 53.6% against 53.3% in Nepal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Guyana and Nepal?
- 0.3%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Nepal?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Nepal rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Guyana ranks 119th and Nepal ranks 121st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.